|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50917431
???header.onlineuser??? :
869
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"mohler m"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2021-09 |
Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements
|
Mohler, M;Goyal, L;Meric-Bernstam, F;Hollebecque, A;Morizane, C;Valle, JW;Karasic, TB;Abrams, TA;Kelley, RK;Cassier, P;Furuse, J;Klumpen, HJ;Chang, HM;Chen, LT;Komatsu, Y;Masuda, K;Ahn, D;He, Y;Soni, N;Benhadji, KA;Bridgewater, JA |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
